|$ in millions, except EPS amounts||Fourth Quarter 2012||Fourth Quarter 2011||Year Ended Dec. 31, 2012||Year Ended Dec. 31, 2011|
|Non-GAAP EPS that excludes items listed below 1||0.83||0.97||3.82||3.77|
|GAAP Net Income 2||1,401||1,512||6,661||6,272|
|Non-GAAP Net Income that excludes items listed below 1,2||2,540||2,978||11,743||11,697|
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2012.
Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.83 and $3.82 for the full year of 2012 exclude acquisition-related costs and restructuring costs.